Summit Therapeutics has revealed that a second pivotal trial of its Akeso-partnered PD-1xVEGF bispecific ivonescimab has failed to show an improvement in overall survival in a lung cancer trial ...

The federal territories of Kuala Lumpur and Putrajaya are also on alert, along with parts of Sarawak — specifically Kuching, Serian, Samarahan and Sri Aman. The department said the warning was ...